Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | lipocurerx.com | |
Description | Corporate contact Home Pipeline LC-100 LC-200 LC-300 LC-400 Science LC-100 LC-200 LC-400 LC-300 Collaborations Our Team Board of Directors Management Publications Sales Con |
Keywords | N/A |
WebSite | lipocurerx.com |
Host IP | 209.182.197.220 |
Location | United States |
Site | Rank |
US$1,711,218
Last updated: 2023-05-12 09:44:43
lipocurerx.com has Semrush global rank of 6,185,246. lipocurerx.com has an estimated worth of US$ 1,711,218, based on its estimated Ads revenue. lipocurerx.com receives approximately 197,449 unique visitors each day. Its web server is located in United States, with IP address 209.182.197.220. According to SiteAdvisor, lipocurerx.com is safe to visit. |
Purchase/Sale Value | US$1,711,218 |
Daily Ads Revenue | US$1,580 |
Monthly Ads Revenue | US$47,388 |
Yearly Ads Revenue | US$568,651 |
Daily Unique Visitors | 13,164 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
lipocurerx.com. | A | 899 | IP: 209.182.197.220 |
lipocurerx.com. | NS | 14400 | NS Record: ns2.webhostinghub.com. |
lipocurerx.com. | NS | 14400 | NS Record: ns1.webhostinghub.com. |
lipocurerx.com. | MX | 900 | MX Record: 0 lipocurerx-com.mail.protection.outlook.com. |
lipocurerx.com. | MX | 900 | MX Record: 32767 ms11164567.msv1.invalid. |
lipocurerx.com. | TXT | 900 | TXT Record: v=spf1 include:spf.protection.outlook.com +a:whub47.webhostinghub.com +a:smtp.servconfig.com +a +mx -all |
Home Pipeline LC-100 LC-200 LC-300 LC-400 Science LC-100 LC-200 LC-400 LC-300 Collaborations Our Team Board of Directors Management Publications Sales Contact Us Select Page LipoCure is developing a number of highly-potent therapeutics utilizing proprietary liposome-based nano-drugs with novel drug-loading-capabilities and drug-release mechanisms. Inflammatory diseases, infection diseases and cancers are treated with very potent drugs that are often associated with severe side effects. It has been shown that effective passive targeting and drug delivery approaches dramatically improve clinical efficacy and safety of many of these potent drugs. The commonly used anti-cancer Doxil®, one of the gold standards of several anticancer therapies, exemplifies such a case. The superior efficacy of Doxil® is due to the major reduction of severe cardiotoxicity of the highly-potent anticancer drug, doxorubicin. This was achieved by the combination of the liposomal delivery technology, |
HTTP/1.1 406 Not Acceptable Date: Sat, 11 Dec 2021 08:54:48 GMT Server: Apache Content-Type: text/html; charset=iso-8859-1 |
Domain Name: LIPOCURERX.COM Registry Domain ID: 1674849345_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2021-07-18T07:17:00Z Creation Date: 2011-09-01T08:14:24Z Registry Expiry Date: 2022-09-01T08:14:24Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Registrar Abuse Contact Email: domainabuse@tucows.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.WEBHOSTINGHUB.COM Name Server: NS2.WEBHOSTINGHUB.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-11T07:48:02Z <<< |